Evidence map›Paper›PMID 42593630›Full record

ArticleRheumatology and therapy2026

Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study.

Rohit Aggarwal, Joachim Schessl, Zsuzsanna Bata-Csörgő, Mazen M Dimachkie, Zoltan Griger, Sergey Moiseev, Chester V Oddis, Elena Schiopu, Jiri Vencovský, Elisabeth Clodi and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Rheumatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Rohit AggarwalDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-7531-8038
Joachim SchesslDepartment of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians University of Munich, Munich, Germany.
Zsuzsanna Bata-CsörgőDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Mazen M DimachkieDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0002-7148-989X
Zoltan GrigerDivision of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.ORCID http://orcid.org/0000-0002-1371-7911
Sergey MoiseevTareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.ORCID http://orcid.org/0000-0002-7232-4640
Chester V OddisDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-9529-3111
Elena SchiopuDivision of Rheumatology, Medical College of Georgia at Augusta University, Augusta, GA, USA.ORCID http://orcid.org/0000-0002-1831-5292
Jiri VencovskýInstitute of Rheumatology, Research Department, and Department of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-0851-0713
Elisabeth ClodiGlobal Medical and Scientific Affairs, Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.
Todd LevinePhoenix Neurological Associates, Ltd., Phoenix, AZ, USA.
Christina Charles-SchoemanDivision of Rheumatology, University of California, 200 Medical Plaza, Los Angeles, CA, 90095, USA. CCharles@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-1768-7019
ProDERM investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42593630
PMCPMC13624198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.